Pages that link to "Q48361745"
Jump to navigation
Jump to search
The following pages link to Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy (Q48361745):
Displaying 38 items.
- Striatal dopamine D2 receptors in tardive dyskinesia: PET study (Q33627591) (← links)
- PET and movement disorders (Q33631701) (← links)
- Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration (Q33753831) (← links)
- Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease (Q34510415) (← links)
- Ageing and the nigrostriatal dopaminergic system (Q34627373) (← links)
- Psychosis and positron tomography (Q36445693) (← links)
- PET: its clinical role in neurology (Q36489599) (← links)
- Positron emission tomography studies of brain receptors (Q36503237) (← links)
- In vivo imaging of neurotransmission and brain receptors in dementia. (Q37124915) (← links)
- Where have we got to with neuroreceptor mapping of the human brain? (Q37893938) (← links)
- Parkinsonism-plus syndromes (Q38634983) (← links)
- Receptors in the basal ganglia (Q39152236) (← links)
- Positron emission tomography and central neurotransmitter systems in movement disorders (Q40508834) (← links)
- Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels (Q41278279) (← links)
- Positron Emission Tomography Studies in Movement Disorders (Q41718477) (← links)
- Parkinsonism and Frontotemporal Dementia: The Clinical Overlap (Q42031244) (← links)
- Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease. (Q42488552) (← links)
- Initial clinical experiences with dopamine D2 receptor imaging by means of 2'-iodospiperone and single-photon emission computed tomography (Q42513051) (← links)
- Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study (Q44060161) (← links)
- Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans (Q45291180) (← links)
- Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders (Q45292482) (← links)
- Quantification of neuroreceptors in the living human brain: III. D2-like dopamine receptors: theory, validation, and changes during normal aging (Q46775657) (← links)
- Neurotransmitter deficits from frontotemporal lobar degeneration (Q47837913) (← links)
- A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Q48147177) (← links)
- PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain (Q48158598) (← links)
- Human brain dopamine receptors in children and aging adults (Q48236020) (← links)
- Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride (Q48324477) (← links)
- Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography (Q48535724) (← links)
- Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET. (Q48628005) (← links)
- The quantitative analysis of D2-dopamine receptors in baboon striatum in vivo with 3-N-[2'-18F]fluoroethylspiperone using positron emission tomography (Q48902212) (← links)
- In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia (Q49068786) (← links)
- A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016) : Reply to Jean-Claude Baron Letter to Editor (Q50466636) (← links)
- Decreased dopamine transporters with age in health human subjects (Q51627612) (← links)
- Initial experience with electroconvulsive therapy for progressive supranuclear palsy (Q52025248) (← links)
- Age-related changes in human D1 dopamine receptors measured by positron emission tomography (Q67898218) (← links)
- PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system (Q68427183) (← links)
- Regional specific binding of [11C]RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET (Q69826129) (← links)
- A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography (Q93527495) (← links)